| Insideraktier | 1 234 255 shares |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Harpoon Therapeutics, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i HARP / Harpoon Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i HARP / Harpoon Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-11 | 2024-03-11 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | 8.000% Series A Redeemable Preferred Stock | D | −10 000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | Common Stock | I | −395 783 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | Common Stock | D | −1 463 386 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Walker Luke Nathaniel | HARP | Common Stock | D | −135 000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | SILVERNAIL LAUREN P | HARP | Common Stock | D | −5 000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | HUNT RONALD | HARP | 8.000% Series A Redeemable Preferred Stock | I | −10 000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | HUNT RONALD | HARP | Common Stock | I | −395 783 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | HUNT RONALD | HARP | Common Stock | I | −1 463 386 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | HUNT RONALD | HARP | Common Stock | D | −13 224 | 0 | ||||||
| 2024-03-11 | 2024-03-08 | 4 | HUNT RONALD | HARP | Common Stock | D | 424 | 13 224 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | −22 665 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Chin Mark | HARP | Common Stock | D | −13 224 | 0 | ||||||
| 2024-03-11 | 2024-03-08 | 4 | Chin Mark | HARP | Common Stock | D | 424 | 13 224 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | DRACHMAN JONATHAN G | HARP | Common Stock | D | −5 415 | 0 | ||||||
| 2024-03-11 | 2024-03-08 | 4 | DRACHMAN JONATHAN G | HARP | Common Stock | D | 415 | 5 415 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Robbins Andrew R | HARP | Common Stock | D | −5 000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | BAILES JOSEPH S | HARP | Common Stock | D | −5 000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | EASTLAND JULIA MARIE | HARP | Common Stock | D | −269 381 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | EASTLAND JULIA MARIE | HARP | Common Stock | D | 31 250 | 269 381 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Lanza Frank J | HARP | Common Stock | D | −18 734 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Merck & Co., Inc. | HARP | Common Stock, par value $0.0001 | I | 23,0000 | 21 397 205 | 492 136 | 1 000 | ||||
| 2024-01-17 | 3 | Merck & Co., Inc. See Footnotes | HARP | Common Stock, par value $0.0001 | I | 0 | ||||||||
| 2024-01-09 | 2024-01-07 | 4 | Lanza Frank J | HARP | Common Stock | D | 15 000 | 18 362 | ||||||
| 2024-01-09 | 2024-01-07 | 4 | EASTLAND JULIA MARIE | HARP | Common Stock | D | 178 500 | 232 003 | ||||||
| 2024-01-09 | 2024-01-07 | 4 | Walker Luke Nathaniel | HARP | Common Stock | D | 115 000 | 135 000 | ||||||
| 2024-01-03 | 2024-01-01 | 4 | Chin Mark | HARP | Common Stock | D | 1 072 | 12 801 | ||||||
| 2024-01-03 | 2024-01-01 | 4 | HUNT RONALD | HARP | Common Stock | D | 1 072 | 12 801 | ||||||
| 2024-01-03 | 2024-01-01 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 2 048 | 22 666 | ||||||
| 2023-11-28 | 2023-11-26 | 4 | Walker Luke Nathaniel | HARP | Common Stock | D | 20 000 | 20 000 | ||||||
| 2023-11-28 | 2023-11-26 | 4 | Lanza Frank J | HARP | Common Stock | D | 2 000 | 3 362 | ||||||
| 2023-11-28 | 2023-11-26 | 4 | EASTLAND JULIA MARIE | HARP | Common Stock | D | 50 000 | 53 503 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | SILVERNAIL LAUREN P | HARP | Common Stock | D | 5 000 | 5 000 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | Robbins Andrew R | HARP | Common Stock | D | 5 000 | 5 000 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 5 000 | 20 618 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | HUNT RONALD | HARP | Common Stock | D | 5 000 | 11 729 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | Chin Mark | HARP | Common Stock | D | 5 000 | 11 729 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | DRACHMAN JONATHAN G | HARP | Common Stock | D | 5 000 | 5 000 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | BAILES JOSEPH S | HARP | Common Stock | D | 5 000 | 5 000 | ||||||
| 2023-10-27 | 2023-10-25 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | Common Stock | I | 171 500 | 395 783 | ||||||
| 2023-10-27 | 2023-10-25 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | Common Stock | D | 1 372 000 | 1 463 386 | ||||||
| 2023-10-27 | 2023-10-25 | 4 | HUNT RONALD | HARP | Common Stock | I | 171 500 | 395 783 | ||||||
| 2023-10-27 | 2023-10-25 | 4 | HUNT RONALD | HARP | Common Stock | I | 1 372 000 | 1 463 386 | ||||||
| 2023-10-02 | 2023-10-01 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 5 797 | 15 618 | ||||||
| 2023-10-02 | 2023-10-01 | 4 | HUNT RONALD | HARP | Common Stock | D | 3 035 | 6 729 | ||||||
| 2023-10-02 | 2023-10-01 | 4 | Chin Mark | HARP | Common Stock | D | 3 035 | 6 729 | ||||||
| 2023-07-06 | 2023-07-01 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 35 634 | 98 215 | ||||||
| 2023-07-06 | 2023-07-01 | 4 | Chin Mark | HARP | Common Stock | D | 18 656 | 36 941 | ||||||
| 2023-07-06 | 2023-07-01 | 4 | HUNT RONALD | HARP | Common Stock | D | 18 656 | 36 941 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Colowick Alan | HARP | Common Stock | D | 16 456 | 16 456 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 34 925 | 62 581 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | HUNT RONALD | HARP | Common Stock | D | 18 285 | 18 285 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Chin Mark | HARP | Common Stock | D | 18 285 | 18 285 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Viney Joanne L. | HARP | Common Stock | D | 21 028 | 21 028 | ||||||
| 2023-03-27 | 3 | Lathi Vijay K See footnotes | HARP | Common Stock | I | 2 242 839 | ||||||||
| 2023-03-27 | 3 | Lathi Vijay K | HARP | Common Stock | D | 913 860 | ||||||||
| 2023-03-27 | 3 | Lathi Vijay K | HARP | 8.000% Series A Redeemable Preferred Stock | D | 10 000 | ||||||||
| 2023-03-27 | 2023-03-23 | 4 | HUNT RONALD | HARP | 8.000% Series A Redeemable Preferred Stock | I | 1 000,0000 | 10 000 | 10 000 | 10 000 | ||||
| 2022-10-04 | 3 | Walker Luke Nathaniel | HARP | No securities are beneficially owned | D | 0 | ||||||||
| 2022-09-19 | 3 | Lanza Frank J | HARP | Common Stock | D | 6 540 | ||||||||
| 2022-09-19 | 3 | SILVERNAIL LAUREN P | HARP | No securities are beneficially owned | D | 0 | ||||||||
| 2022-02-01 | 2022-01-28 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 5,03 | 135 000 | 135 000 | |||||
| 2022-02-01 | 2022-01-28 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 5,03 | 155 000 | 155 000 | |||||
| 2022-02-01 | 2022-01-28 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 5,03 | 115 000 | 115 000 | |||||
| 2021-11-15 | 2021-11-11 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 7,73 | 135 000 | 135 000 | |||||
| 2021-11-15 | 2021-11-11 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 7,73 | 155 000 | 155 000 | |||||
| 2021-11-15 | 2021-11-11 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 7,73 | 115 000 | 115 000 | |||||
| 2021-11-09 | 2021-11-08 | 4 | EASTLAND JULIA MARIE | HARP | Stock Option (Right to Buy) | D | 6,85 | 350 000 | 350 000 | |||||
| 2021-10-26 | 2021-10-25 | 4 | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 6,31 | 10 167 | 10 167 | |||||
| 2021-09-22 | 2021-09-22 | 4 | Erbez Georgia By IRA | HARP | Common Stock | I | 8,1000 | 10 300 | 83 | 19 215 | ||||
| 2021-08-12 | 2021-01-11 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 17,0000 | 235 294 | 4 000 | 913 860 | ||||
| 2021-08-12 | 2021-01-11 | 4 | HUNT RONALD | HARP | Common Stock | I | 17,0000 | 235 294 | 4 000 | 913 860 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | −10 000 | 21 002 | |||||
| 2021-07-06 | 2021-07-01 | 4 | Wesche Holger | HARP | Common Stock | D | 14,0000 | −10 000 | −140 | 52 852 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 10 000 | 6 | 62 852 | ||||
| 2021-06-02 | 2021-06-02 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,5000 | −25 118 | −515 | 6 328 095 | ||||
| 2021-06-02 | 2021-06-01 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,4400 | −18 491 | −378 | 6 353 213 | ||||
| 2021-06-02 | 2021-05-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,6000 | −100 | −2 | 6 371 704 | ||||
| 2021-06-02 | 2021-05-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21,9200 | −3 100 | −68 | 6 371 804 | ||||
| 2021-06-02 | 2021-05-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,8800 | −10 685 | −223 | 6 374 904 | ||||
| 2021-05-27 | 2021-05-27 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,2600 | −13 961 | −283 | 6 385 589 | ||||
| 2021-05-27 | 2021-05-26 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0400 | −3 198 | −64 | 6 399 550 | ||||
| 2021-05-24 | 2021-05-24 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,1200 | −5 000 | −101 | 6 402 748 | ||||
| 2021-05-24 | 2021-05-21 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,2100 | −10 907 | −220 | 6 407 748 | ||||
| 2021-05-20 | 2021-05-20 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,3400 | −11 713 | −238 | 6 418 655 | ||||
| 2021-05-20 | 2021-05-19 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,3900 | −17 833 | −364 | 6 430 368 | ||||
| 2021-05-20 | 2021-05-18 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,6700 | −18 402 | −380 | 6 448 201 | ||||
| 2021-05-17 | 2021-05-17 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0700 | −4 666 | −94 | 6 466 603 | ||||
| 2021-05-17 | 2021-05-14 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0400 | −6 900 | −138 | 6 471 269 | ||||
| 2021-05-17 | 2021-05-13 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0600 | −4 855 | −97 | 6 478 169 | ||||
| 2021-05-14 | 2021-05-04 | 4/A | Viney Joanne L. | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 2 571 | 2 571 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Viney Joanne L. | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10 167 | 10 167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | BAILES JOSEPH S | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10 167 | 10 167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Robbins Andrew R | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10 167 | 10 167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10 167 | 10 167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10 167 | 10 167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 4 658 | 4 658 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10 167 | 10 167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10 167 | 10 167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 2 438 | 2 438 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10 167 | 10 167 | |||||
| 2021-05-12 | 2021-05-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,5300 | −29 684 | −609 | 6 483 024 | ||||
| 2021-05-12 | 2021-05-11 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21,5100 | −7 672 | −165 | 6 512 708 | ||||
| 2021-05-12 | 2021-05-11 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,9600 | −13 773 | −289 | 6 520 380 | ||||
| 2021-05-12 | 2021-05-10 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,4600 | −411 | −9 | 6 534 153 | ||||
| 2021-05-12 | 2021-05-10 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21,7800 | −16 722 | −364 | 6 534 564 | ||||
| 2021-05-07 | 2021-05-04 | 4 | Colowick Alan | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10 167 | 10 167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Viney Joanne L. | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 2 653 | 2 653 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Viney Joanne L. | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10 167 | 10 167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | BAILES JOSEPH S | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10 167 | 10 167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10 167 | 10 167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Robbins Andrew R | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10 167 | 10 167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10 167 | 10 167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 4 807 | 4 807 | |||||
| 2021-05-07 | 2021-05-04 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10 167 | 10 167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10 167 | 10 167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 3 017 | 3 017 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10 167 | 10 167 | |||||
| 2021-05-06 | 2021-05-05 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23,0900 | −59 | −1 | 6 551 286 | ||||
| 2021-05-06 | 2021-05-05 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,5200 | −10 113 | −228 | 6 551 345 | ||||
| 2021-05-04 | 2021-05-04 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23,3300 | −3 500 | −82 | 6 561 458 | ||||
| 2021-05-04 | 2021-05-04 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23,0300 | −26 230 | −604 | 6 564 958 | ||||
| 2021-05-04 | 2021-05-03 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23,4500 | −4 401 | −103 | 6 591 188 | ||||
| 2021-05-04 | 2021-05-03 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23,0300 | −26 365 | −607 | 6 595 589 | ||||
| 2021-05-04 | 2021-04-30 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,3500 | −268 023 | −5 990 | 6 621 954 | ||||
| 2021-04-29 | 2021-04-29 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,5400 | −21 781 | −491 | 6 889 977 | ||||
| 2021-04-29 | 2021-04-29 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,0200 | −45 511 | −1 002 | 6 911 758 | ||||
| 2021-04-29 | 2021-04-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,0100 | −36 803 | −810 | 6 957 269 | ||||
| 2021-04-29 | 2021-04-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21,6400 | −14 219 | −308 | 6 994 072 | ||||
| 2021-04-29 | 2021-04-27 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21,2600 | −8 328 | −177 | 7 008 291 | ||||
| 2021-04-29 | 2021-04-27 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,9900 | −3 501 | −73 | 7 016 619 | ||||
| 2021-04-22 | 2021-04-21 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19,4800 | −555 | −11 | 7 020 120 | ||||
| 2021-04-22 | 2021-04-21 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 18,9400 | −8 417 | −159 | 7 020 675 | ||||
| 2021-04-20 | 2021-04-20 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19,0900 | −834 | −16 | 7 029 092 | ||||
| 2021-04-20 | 2021-04-20 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 18,7000 | −21 415 | −400 | 7 029 926 | ||||
| 2021-04-20 | 2021-04-19 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0800 | −100 | −2 | 7 051 341 | ||||
| 2021-04-20 | 2021-04-19 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19,2900 | −9 956 | −192 | 7 051 441 | ||||
| 2021-04-20 | 2021-04-16 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,5600 | −300 | −6 | 7 061 397 | ||||
| 2021-04-20 | 2021-04-16 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19,8200 | −5 547 | −110 | 7 061 697 | ||||
| 2021-04-15 | 2021-04-15 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,4900 | −1 052 | −22 | 3 220 844 | ||||
| 2021-04-15 | 2021-04-14 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,8300 | −1 550 | −32 | 3 221 896 | ||||
| 2021-04-15 | 2021-04-14 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,0600 | −121 | −2 | 3 223 446 | ||||
| 2021-04-15 | 2021-04-13 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,0800 | −286 | −6 | 3 223 567 | ||||
| 2021-04-15 | 2021-04-13 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 19,3500 | −1 657 | −32 | 3 223 853 | ||||
| 2021-04-15 | 2021-04-15 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,4900 | −8 696 | −178 | 7 067 244 | ||||
| 2021-04-15 | 2021-04-14 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,8300 | −12 806 | −267 | 7 075 940 | ||||
| 2021-04-15 | 2021-04-14 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0600 | −1 000 | −20 | 7 088 746 | ||||
| 2021-04-15 | 2021-04-13 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0800 | −2 362 | −47 | 7 089 746 | ||||
| 2021-04-15 | 2021-04-13 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19,3500 | −13 692 | −265 | 7 092 108 | ||||
| 2021-04-13 | 2021-04-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,6800 | −400 | −9 | 7 105 800 | ||||
| 2021-04-13 | 2021-04-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21,5200 | −6 700 | −144 | 7 106 200 | ||||
| 2021-04-13 | 2021-04-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,7200 | −13 528 | −280 | 7 112 900 | ||||
| 2021-04-13 | 2021-04-09 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23,6700 | −10 300 | −244 | 7 126 428 | ||||
| 2021-04-13 | 2021-04-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 22,6800 | −48 | −1 | 3 225 510 | ||||
| 2021-04-13 | 2021-04-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 21,5200 | −811 | −17 | 3 225 558 | ||||
| 2021-04-13 | 2021-04-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,7200 | −1 637 | −34 | 3 226 369 | ||||
| 2021-04-13 | 2021-04-09 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 23,6700 | −10 300 | −244 | 3 228 006 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | −1 534 | 31 002 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | −8 466 | 2 540 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Common Stock | D | 21,1400 | −500 | −11 | 52 852 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Common Stock | D | 20,4127 | −9 500 | −194 | 53 352 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 1 534 | 1 | 62 852 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 8 466 | 5 | 61 318 | ||||
| 2021-03-26 | 2021-03-24 | 4 | Colowick Alan | HARP | Director Stock Option (right to buy) | D | 19,63 | 20 335 | 20 335 | |||||
| 2021-02-18 | 2021-02-17 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 2,12 | −25 000 | 145 908 | |||||
| 2021-02-18 | 2021-02-17 | 4 | Erbez Georgia | HARP | Common Stock | D | 2,1200 | 25 000 | 53 | 72 292 | ||||
| 2021-02-12 | 2021-02-10 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,0000 | −183 051 | −3 661 | 3 238 306 | ||||
| 2021-02-09 | 2021-02-09 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,2500 | −9 400 | −190 | 3 421 357 | ||||
| 2021-02-09 | 2021-02-08 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,0400 | −72 128 | −1 445 | 3 430 757 | ||||
| 2021-02-09 | 2021-02-05 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,0100 | −10 172 | −204 | 3 502 885 | ||||
| 2021-02-04 | 2021-02-04 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,3700 | −29 730 | −606 | 3 513 057 | ||||
| 2021-02-04 | 2021-02-03 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,2100 | −41 922 | −847 | 3 542 787 | ||||
| 2021-02-04 | 2021-02-02 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,1300 | −48 421 | −975 | 3 584 709 | ||||
| 2021-01-29 | 2021-01-28 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 18,66 | 52 000 | 52 000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 18,66 | 80 000 | 80 000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 18,66 | 72 000 | 72 000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | McMahon Gerald PhD | HARP | Employee Stock Option (right to buy) | D | 18,66 | 181 470 | 181 470 | |||||
| 2021-01-27 | 2021-01-27 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,0000 | −706 825 | −14 136 | 3 633 130 | ||||
| 2021-01-27 | 2021-01-26 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 21,0800 | −1 363 | −29 | 4 339 955 | ||||
| 2021-01-27 | 2021-01-25 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 21,2300 | −13 006 | −276 | 4 341 318 | ||||
| 2021-01-22 | 2021-01-22 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 21,7200 | −24 695 | −536 | 4 354 324 | ||||
| 2021-01-22 | 2021-01-21 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 23,7700 | −200 | −5 | 4 379 019 | ||||
| 2021-01-22 | 2021-01-21 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 22,6100 | −4 887 | −110 | 4 379 219 | ||||
| 2021-01-22 | 2021-01-21 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 22,1100 | −20 979 | −464 | 4 384 106 | ||||
| 2021-01-22 | 2021-01-20 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | −101 646 | 4 405 085 | ||||||
| 2021-01-22 | 2021-01-20 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 24,7100 | −2 000 | −49 | 4 506 731 | ||||
| 2021-01-22 | 2021-01-20 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 23,9500 | −15 694 | −376 | 4 508 731 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | −10 000 | 11 006 | |||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Common Stock | D | 19,3935 | −3 549 | −69 | 52 852 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Common Stock | D | 18,3010 | −3 351 | −61 | 56 401 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Common Stock | D | 17,3170 | −3 100 | −54 | 59 752 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 10 000 | 6 | 62 852 | ||||
| 2020-10-05 | 2020-10-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | −10 000 | 21 006 | |||||
| 2020-10-05 | 2020-10-01 | 4 | Wesche Holger | HARP | Common Stock | D | 17,0299 | −1 000 | −17 | 52 669 | ||||
| 2020-10-05 | 2020-10-01 | 4 | Wesche Holger | HARP | Common Stock | D | 16,1897 | −9 000 | −146 | 53 669 | ||||
| 2020-10-05 | 2020-10-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 10 000 | 6 | 62 669 | ||||
| 2020-08-20 | 2020-08-19 | 4 | Erbez Georgia | HARP | Common Stock | I | 11,4000 | 5 000 | 57 | 8 915 | ||||
| 2020-08-20 | 2020-08-18 | 4 | Erbez Georgia | HARP | Common Stock | I | 11,6000 | 2 098 | 24 | 3 915 | ||||
| 2020-08-04 | 2020-07-31 | 4 | Erbez Georgia | HARP | Common Stock | I | 10,9200 | 1 817 | 20 | 1 817 | ||||
| 2020-07-02 | 2020-07-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | −10 000 | 31 006 | |||||
| 2020-07-02 | 2020-07-01 | 4 | Wesche Holger | HARP | Common Stock | D | 16,1989 | −10 000 | −162 | 52 669 | ||||
| 2020-07-02 | 2020-07-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 10 000 | 6 | 62 669 | ||||
| 2020-07-02 | 2020-07-01 | 4 | Viney Joanne L. | HARP | Director Stock Option (right to buy) | D | 17,49 | 20 335 | 20 335 | |||||
| 2020-06-01 | 2020-05-28 | 4 | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10 167 | 10 167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10 167 | 10 167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 2 880 | 2 880 | |||||
| 2020-06-01 | 2020-05-28 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10 167 | 10 167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 4 906 | 4 906 | |||||
| 2020-06-01 | 2020-05-28 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10 167 | 10 167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 3 587 | 3 587 | |||||
| 2020-06-01 | 2020-05-28 | 4 | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10 167 | 10 167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Baeuerle Patrick | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 2 584 | 2 584 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Baeuerle Patrick | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10 167 | 10 167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 3 017 | 3 017 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10 167 | 10 167 | |||||
| 2020-05-29 | 2020-05-28 | 4 | Arix Bioscience plc | HARP | Common stock | I | 21,3342 | −366 591 | −7 821 | 2 193 704 | ||||
| 2020-05-29 | 2020-05-27 | 4 | Arix Bioscience plc | HARP | Common stock | I | 22,3926 | −12 064 | −270 | 2 560 295 | ||||
| 2020-05-20 | 2020-05-18 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −1 522 | 45 625 | |||||
| 2020-05-20 | 2020-05-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 14,7691 | −1 522 | −22 | 45 754 | ||||
| 2020-05-20 | 2020-05-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1 522 | 3 | 47 276 | ||||
| 2020-05-13 | 2020-05-12 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | −1 400 | 41 006 | |||||
| 2020-05-13 | 2020-05-12 | 4 | Wesche Holger | HARP | Common Stock | D | 14,0857 | −1 400 | −20 | 52 669 | ||||
| 2020-05-13 | 2020-05-12 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 1 400 | 1 | 54 069 | ||||
| 2020-05-11 | 2020-05-11 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | −1 000 | 42 406 | |||||
| 2020-05-11 | 2020-05-11 | 4 | Wesche Holger | HARP | Common Stock | D | 14,0651 | −1 000 | −14 | 52 669 | ||||
| 2020-05-11 | 2020-05-11 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 1 000 | 1 | 53 669 | ||||
| 2020-05-11 | 2020-05-08 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | −1 000 | 43 406 | |||||
| 2020-05-11 | 2020-05-08 | 4 | Wesche Holger | HARP | Common Stock | D | 14,0000 | −1 000 | −14 | 52 669 | ||||
| 2020-05-11 | 2020-05-08 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 1 000 | 1 | 53 669 | ||||
| 2020-05-11 | 2020-05-07 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | −5 350 | 44 406 | |||||
| 2020-05-11 | 2020-05-07 | 4 | Wesche Holger | HARP | Common Stock | D | 14,1263 | −5 350 | −76 | 52 669 | ||||
| 2020-05-11 | 2020-05-07 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 5 350 | 3 | 58 019 | ||||
| 2020-05-05 | 2020-05-01 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −5 826 | 168 926 | |||||
| 2020-05-05 | 2020-05-01 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0668 | −5 826 | −70 | 45 754 | ||||
| 2020-05-05 | 2020-05-01 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 5 826 | 12 | 51 580 | ||||
| 2020-04-30 | 2020-04-28 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | −1 250 | 49 756 | |||||
| 2020-04-30 | 2020-04-28 | 4 | Wesche Holger | HARP | Common Stock | D | 14,0520 | −1 250 | −18 | 52 669 | ||||
| 2020-04-30 | 2020-04-28 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 1 250 | 1 | 53 919 | ||||
| 2020-04-17 | 2020-04-17 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −1 021 | 47 147 | |||||
| 2020-04-17 | 2020-04-17 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0765 | −1 021 | −12 | 45 754 | ||||
| 2020-04-17 | 2020-04-17 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1 021 | 2 | 46 775 | ||||
| 2020-04-17 | 2020-04-16 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −500 | 48 168 | |||||
| 2020-04-17 | 2020-04-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0000 | −500 | −6 | 45 754 | ||||
| 2020-04-17 | 2020-04-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 500 | 1 | 46 254 | ||||
| 2020-04-15 | 2020-04-13 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −4 556 | 174 752 | |||||
| 2020-04-15 | 2020-04-13 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0630 | −4 556 | −55 | 45 754 | ||||
| 2020-04-15 | 2020-04-13 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 4 556 | 10 | 50 310 | ||||
| 2020-04-08 | 2020-04-07 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −570 | 179 308 | |||||
| 2020-04-08 | 2020-04-07 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0000 | −570 | −7 | 45 754 | ||||
| 2020-04-08 | 2020-04-07 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 570 | 1 | 46 324 | ||||
| 2020-04-08 | 2020-04-06 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −700 | 179 878 | |||||
| 2020-04-08 | 2020-04-06 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0014 | −700 | −8 | 45 754 | ||||
| 2020-04-08 | 2020-04-06 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 700 | 1 | 46 454 | ||||
| 2020-04-01 | 2020-03-30 | 4 | Robbins Andrew R | HARP | Director Stock Option (right to buy) | D | 11,78 | 20 335 | 20 335 | |||||
| 2020-04-01 | 2020-03-30 | 4 | BAILES JOSEPH S | HARP | Director Stock Option (right to buy) | D | 11,78 | 20 335 | 20 335 | |||||
| 2020-03-18 | 2020-03-17 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −1 520 | 48 668 | |||||
| 2020-03-18 | 2020-03-17 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0000 | −1 520 | −18 | 45 754 | ||||
| 2020-03-18 | 2020-03-17 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1 520 | 3 | 47 274 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −1 | 50 188 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0000 | −1 | −0 | 45 754 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1 | 0 | 45 755 | ||||
| 2020-03-03 | 2020-03-02 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −5 826 | 180 578 | |||||
| 2020-03-03 | 2020-03-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 14,6800 | −5 826 | −86 | 45 754 | ||||
| 2020-03-03 | 2020-03-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 5 826 | 12 | 51 580 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −1 521 | 50 189 | |||||
| 2020-02-20 | 2020-02-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 15,0000 | −1 521 | −23 | 45 754 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1 521 | 3 | 47 275 | ||||
| 2020-02-04 | 2020-01-31 | 4 | McMahon Gerald PhD | HARP | Employee Stock Option (right to buy) | D | 13,29 | 165 210 | 165 210 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 13,29 | 52 160 | 52 160 | |||||
| 2020-02-04 | 2020-02-03 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −5 826 | 186 404 | |||||
| 2020-02-04 | 2020-02-03 | 4 | Sacks Natalie | HARP | Common Stock | D | 13,9043 | −5 826 | −81 | 45 754 | ||||
| 2020-02-04 | 2020-02-03 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 5 826 | 12 | 51 580 | ||||
| 2020-02-04 | 2020-01-31 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 13,29 | 75 440 | 75 440 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 13,29 | 52 313 | 52 313 | |||||
| 2020-01-23 | 2020-01-21 | 4 | Erbez Georgia | HARP | Common Stock | I | 14,0922 | 6 700 | 94 | 6 700 | ||||
| 2020-01-21 | 2020-01-16 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −1 521 | 51 710 | |||||
| 2020-01-21 | 2020-01-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 14,9408 | −1 521 | −23 | 45 754 | ||||
| 2020-01-21 | 2020-01-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1 521 | 3 | 47 275 | ||||
| 2020-01-06 | 2020-01-02 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | −10 000 | 51 006 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Wesche Holger | HARP | Common Stock | D | 14,3987 | −10 000 | −144 | 52 669 | ||||
| 2020-01-06 | 2020-01-02 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 10 000 | 6 | 62 669 | ||||
| 2020-01-06 | 2020-01-02 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −5 826 | 192 230 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 14,1779 | −5 826 | −83 | 45 754 | ||||
| 2020-01-06 | 2020-01-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 5 826 | 12 | 51 580 | ||||
| 2019-12-30 | 2019-12-27 | 4 | Baeuerle Patrick | HARP | Common Stock | I | 18,0690 | −1 400 | −25 | 262 136 | ||||
| 2019-12-30 | 2019-12-27 | 4 | Baeuerle Patrick | HARP | Common Stock | I | 16,9014 | −10 417 | −176 | 263 536 | ||||
| 2019-12-30 | 2019-12-27 | 4 | Baeuerle Patrick | HARP | Common Stock | I | 15,8138 | −75 562 | −1 195 | 273 953 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −1 521 | 53 231 | |||||
| 2019-12-18 | 2019-12-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 17,0201 | −1 521 | −26 | 45 754 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1 521 | 3 | 47 275 | ||||
| 2019-12-17 | 2019-12-17 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 16,8298 | −12 476 | −210 | 2 572 359 | ||||
| 2019-12-17 | 2019-12-16 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 17,0245 | −13 080 | −223 | 2 584 835 | ||||
| 2019-12-17 | 2019-12-13 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 17,2097 | −11 002 | −189 | 2 597 915 | ||||
| 2019-12-17 | 2019-12-17 | 4 | Arix Bioscience plc | HARP | Common stock | I | 16,8298 | −12 476 | −210 | 2 572 359 | ||||
| 2019-12-17 | 2019-12-16 | 4 | Arix Bioscience plc | HARP | Common stock | I | 17,0245 | −13 080 | −223 | 2 584 835 | ||||
| 2019-12-17 | 2019-12-13 | 4 | Arix Bioscience plc | HARP | Common stock | I | 17,2097 | −11 002 | −189 | 2 597 915 | ||||
| 2019-12-10 | 2019-12-10 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 16,9103 | −131 696 | −2 227 | 2 608 917 | ||||
| 2019-12-10 | 2019-12-09 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 18,1161 | −77 316 | −1 401 | 2 740 613 | ||||
| 2019-12-10 | 2019-12-09 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 18,2987 | −26 438 | −484 | 2 817 929 | ||||
| 2019-12-10 | 2019-12-06 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 19,1452 | −47 752 | −914 | 2 844 367 | ||||
| 2019-12-10 | 2019-12-10 | 4 | Arix Bioscience plc | HARP | Common stock | I | 16,9103 | −131 696 | −2 227 | 2 608 917 | ||||
| 2019-12-10 | 2019-12-09 | 4 | Arix Bioscience plc | HARP | Common stock | I | 18,1161 | −77 316 | −1 401 | 2 740 613 | ||||
| 2019-12-10 | 2019-12-09 | 4 | Arix Bioscience plc | HARP | Common stock | I | 18,2987 | −26 438 | −484 | 2 817 929 | ||||
| 2019-12-10 | 2019-12-06 | 4 | Arix Bioscience plc | HARP | Common stock | I | 19,1452 | −47 752 | −914 | 2 844 367 | ||||
| 2019-12-06 | 2019-12-04 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 2,12 | −47 292 | 170 908 | |||||
| 2019-12-06 | 2019-12-04 | 4 | Erbez Georgia | HARP | Common Stock | D | 2,1200 | 47 292 | 100 | 47 292 | ||||
| 2019-12-04 | 2019-12-02 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −5 826 | 198 056 | |||||
| 2019-12-04 | 2019-12-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 17,9800 | −5 826 | −105 | 45 754 | ||||
| 2019-12-04 | 2019-12-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 5 826 | 12 | 51 580 | ||||
| 2019-11-19 | 2019-11-18 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −18 252 | 54 752 | |||||
| 2019-11-19 | 2019-11-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 14,0000 | −1 000 | −14 | 45 754 | ||||
| 2019-11-19 | 2019-11-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 13,3297 | −17 252 | −230 | 46 754 | ||||
| 2019-11-19 | 2019-11-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 18 252 | 39 | 64 006 | ||||
| 2019-11-05 | 2019-11-01 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −5 826 | 203 882 | |||||
| 2019-11-05 | 2019-11-01 | 4 | Sacks Natalie | HARP | Common Stock | D | 13,1654 | −5 826 | −77 | 45 754 | ||||
| 2019-11-05 | 2019-11-01 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 5 826 | 12 | 51 580 | ||||
| 2019-10-16 | 2019-10-15 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −11 698 | 209 708 | |||||
| 2019-10-16 | 2019-10-15 | 4 | Sacks Natalie | HARP | Common Stock | D | 13,2058 | −11 698 | −154 | 45 754 | ||||
| 2019-10-16 | 2019-10-15 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 11 698 | 25 | 57 452 | ||||
| 2019-10-16 | 2019-10-14 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | −12 452 | 221 406 | |||||
| 2019-10-16 | 2019-10-14 | 4 | Sacks Natalie | HARP | Common Stock | D | 13,2734 | −12 452 | −165 | 45 754 | ||||
| 2019-10-16 | 2019-10-14 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 12 452 | 26 | 58 206 | ||||
| 2019-09-06 | 2019-06-05 | 4 | McMahon Gerald PhD | HARP | Employee Stock Option (right to buy) | D | 0,60 | −169 462 | 318 590 | |||||
| 2019-09-06 | 2019-06-05 | 4 | McMahon Gerald PhD | HARP | Common Stock | D | 0,6000 | 169 462 | 102 | 172 462 | ||||
| 2019-06-05 | 2019-06-03 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10 167 | 10 167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10 167 | 10 167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10 167 | 10 167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10 167 | 10 167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10 167 | 10 167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | Baeuerle Patrick | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10 167 | 10 167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10 167 | 10 167 | |||||
| 2019-05-16 | 2019-05-14 | 4 | McMahon Gerald PhD | HARP | Common Stock | D | 10,1573 | 1 000 | 10 | 3 000 | ||||
| 2019-05-10 | 2019-05-08 | 4 | McMahon Gerald PhD | HARP | Common Stock | D | 10,5587 | 1 000 | 11 | 2 000 | ||||
| 2019-05-07 | 2019-05-03 | 4 | McMahon Gerald PhD | HARP | Common Stock | D | 10,5300 | 1 000 | 11 | 1 000 | ||||
| 2019-03-29 | 2019-02-07 | 4/A | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 14,00 | 6 071 | 6 071 | |||||
| 2019-03-29 | 2019-02-07 | 4/A | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 14,00 | 7 658 | 7 658 | |||||
| 2019-03-29 | 2019-02-07 | 4/A | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 14,00 | 4 923 | 4 923 | |||||
| 2019-03-29 | 2019-02-07 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 14,00 | 4 266 | 4 266 | |||||
| 2019-03-29 | 2019-02-07 | 4 | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 14,00 | 5 907 | 5 907 | |||||
| 2019-03-29 | 2019-02-07 | 4 | Baeuerle Patrick | HARP | Director Stock Option (Right to Buy) | D | 14,00 | 3 829 | 3 829 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Arix Bioscience plc | HARP | Series C Convertible Preferred Stock | I | −742 850 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Arix Bioscience plc | HARP | Series B Convertible Preferred Stock | I | −1 720 698 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Arix Bioscience plc | HARP | Common stock | I | 14,0000 | 428 571 | 6 000 | 2 892 119 | ||||
| 2019-02-14 | 2019-02-12 | 4 | Arix Bioscience plc | HARP | Common stock | I | 2 463 548 | 2 463 548 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −50 837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −50 837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −76 256 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −171 579 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −57 192 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −25 418 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Series C Preferred Stock | I | −417 852 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Series B Preferred Stock | I | −1 578 751 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Series A Preferred Stock | I | −1 525 164 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 14,0000 | 250 000 | 3 500 | 4 524 425 | ||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 14,0000 | −1 524 | −21 | 4 274 425 | ||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 0,0492 | 432 119 | 21 | 4 275 949 | ||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 417 852 | 3 843 830 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 1 578 751 | 3 425 978 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 1 525 164 | 1 847 227 | ||||||
| 2019-02-14 | 2018-12-19 | 4 | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 2,12 | 20 335 | 20 335 | |||||
| 2019-02-14 | 2018-11-09 | 4 | EVNIN LUKE | HARP | Series C Preferred Stock | I | 417 852 | 417 852 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Series C Preferred Stock | I | −742 850 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Series B Preferred Stock | I | −1 720 698 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 14,0000 | 428 571 | 6 000 | 2 892 119 | ||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 742 850 | 2 463 548 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 1 720 698 | 1 720 698 | ||||||
| 2019-02-14 | 2018-12-19 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 2,12 | 20 335 | 20 335 | |||||
| 2019-02-14 | 2018-11-09 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Series C Preferred Stock | I | 742 850 | 742 850 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −101 675 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −152 514 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −50 837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −171 579 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −57 192 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −25 418 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Series C Preferred Stock | I | −835 705 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Series B Preferred Stock | I | −3 157 506 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Series A Preferred Stock | I | −3 050 329 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 14,0000 | 500 000 | 7 000 | 8 422 847 | ||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 14,0000 | −1 971 | −28 | 7 922 847 | ||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 0,0492 | 559 215 | 28 | 7 924 818 | ||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 835 705 | 7 365 603 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 3 157 506 | 6 529 898 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 3 050 329 | 3 372 392 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Series C Convertible Preferred Stock | I | −464 281 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Series C Convertible Preferred Stock | I | −464 281 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Series B Convertible Preferred Stock | I | −1 564 272 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 14,0000 | 214 285 | 3 000 | 678 566 | ||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 14,0000 | 214 286 | 3 000 | 2 242 839 | ||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 464 281 | 464 281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 464 281 | 464 281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 1 564 272 | 1 564 272 | ||||||
| 2019-02-14 | 2018-12-19 | 4 | HUNT RONALD | HARP | Director Stock Option (right to buy) | D | 2,12 | 20 335 | 20 335 | |||||
| 2019-02-14 | 2018-11-09 | 4 | HUNT RONALD | HARP | Series C Convertible Preferred Stock | I | 464 281 | 464 281 | ||||||
| 2019-02-14 | 2018-11-09 | 4 | HUNT RONALD | HARP | Series C Convertible Preferred Stock | I | 464 281 | 464 281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −50 837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −50 837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −76 256 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −171 579 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −57 192 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | −25 418 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Series C Preferred Stock | I | −417 852 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Series B Preferred Stock | I | −1 578 751 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Series A Preferred Stock | I | −1 525 164 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 14,0000 | 250 000 | 3 500 | 4 524 425 | ||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 14,0000 | −1 524 | −21 | 4 274 425 | ||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 0,0492 | 432 119 | 21 | 4 275 949 | ||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 417 852 | 3 843 830 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 1 578 751 | 3 425 978 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 1 525 164 | 1 847 227 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Series C Convertible Preferred Stock | I | −464 281 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Series C Convertible Preferred Stock | I | −464 281 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Series B Convertible Preferred Stock | I | −1 564 272 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 14,0000 | 214 285 | 3 000 | 678 566 | ||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 14,0000 | 214 286 | 3 000 | 2 242 839 | ||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 464 281 | 464 281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 464 281 | 464 281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 1 564 272 | 1 564 272 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock Warrant (Right to Buy) | D | 0,05 | −50 838 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock Warrant (Right to Buy) | D | 0,05 | −76 258 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Series C Preferred Stock | D | −417 853 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Series B Preferred Stock | D | −1 578 755 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Series A Preferred Stock | D | −1 525 165 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 14,0000 | 250 000 | 3 500 | 3 898 422 | ||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 14,0000 | −447 | −6 | 3 648 422 | ||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 0,0492 | 127 096 | 6 | 3 648 869 | ||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 417 853 | 3 521 773 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 1 578 755 | 3 103 920 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 1 525 165 | 1 525 165 | ||||||
| 2019-02-07 | 3 | Myers Scott Dunseth | HARP | Common Stock | D | 55 312 | ||||||||
| 2019-02-07 | 3 | Myers Scott Dunseth | HARP | Common Stock | D | 55 312 | ||||||||
| 2019-02-07 | 3 | Myers Scott Dunseth | HARP | Common Stock | D | 55 312 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | GADICKE ANSBERT | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | GADICKE ANSBERT | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | GADICKE ANSBERT | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | Baeuerle Patrick | HARP | Common Stock | I | 699 030 | ||||||||
| 2019-02-07 | 3 | Baeuerle Patrick | HARP | Common Stock | I | 699 030 | ||||||||
| 2019-02-07 | 3 | Baeuerle Patrick | HARP | Common Stock | I | 699 030 | ||||||||
| 2019-02-07 | 3 | EVNIN LUKE | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | EVNIN LUKE | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | EVNIN LUKE | HARP | Common Stock | I | 644 126 | ||||||||
| 2019-02-07 | 3 | Sacks Natalie | HARP | Common Stock | D | 91 508 | ||||||||
| 2019-02-07 | 3 | Sacks Natalie | HARP | Common Stock | D | 91 508 | ||||||||
| 2019-02-07 | 3 | Sacks Natalie | HARP | Common Stock | D | 91 508 | ||||||||
| 2019-02-07 | 3 | Wesche Holger | HARP | Common Stock | D | 105 338 | ||||||||
| 2019-02-07 | 3 | Wesche Holger | HARP | Common Stock | D | 105 338 | ||||||||
| 2019-02-07 | 3 | Wesche Holger | HARP | Common Stock | D | 105 338 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
